| P2093 | author name string | Yan Wang | |
| | Hong Wang | |
| | Li Lin | |
| | Sheng Li | |
| | Guanglin Cui | |
| | Daowen Wang | |
| | Chunxia Zhao | |
| | Xiaomei Guo | |
| | Jiangang Jiang | |
| | Jiarong Tang | |
| | Jiangtao Yan | |
| | Hesong Zeng | |
| | Editorial Board of Chinese Journal of Cardiology | |
| | Houjuan Zuo | |
| | Yexin Ma | |
| | Section of Precision Medicine Group of Chinese Society of Cardiology | |
| | Working Group of Adult Fulminant Myocarditis | |
| P2860 | cites work | Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock | Q24187111 |
| | Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema | Q24202909 |
| | Corticosteroids for viral myocarditis | Q24202995 |
| | Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients | Q26738599 |
| | Update on myocarditis | Q27000204 |
| | 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of [...] | Q28087002 |
| | A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan | Q30392500 |
| | A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and postpandemic season in Japan | Q30422673 |
| | [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of In | Q33399192 |
| | Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy | Q33564564 |
| | Rapid Resolution of Acute Fulminant Myocarditis after IVIG and Steroid Treatment | Q33566037 |
| | Echocardiographic findings in myocarditis | Q34049809 |
| | Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema | Q34113511 |
| | Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure | Q34139611 |
| | 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut | Q34527664 |
| | ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the | Q34640762 |
| | Prognosis of patients with fulminant myocarditis managed by peripheral venoarterial extracorporeal membranous oxygenation support: a retrospective single-center study. | Q35107113 |
| | Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1 | Q36506880 |
| | Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature | Q37092834 |
| | Fulminant myocarditis | Q37271422 |
| | Fulminant Myocarditis with Combination Immune Checkpoint Blockade | Q37595462 |
| | 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. | Q37964168 |
| | Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. | Q38119180 |
| | Fulminant myocarditis | Q38119673 |
| | Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options | Q38203822 |
| | Intra-aortic balloon pump: indications, efficacy, guidelines and future directions | Q38213479 |
| | Immunoadsorption therapy in dilated cardiomyopathy | Q38286190 |
| | Extracorporeal membrane oxygenation for the support of adults with acute myocarditis | Q38367583 |
| | Viral myocarditis--diagnosis, treatment options, and current controversies | Q38551013 |
| | Magnetic resonance imaging for characterizing myocardial diseases | Q38736889 |
| | Emerging pharmacologic targets and treatments for myocarditis | Q38786885 |
| | Established and novel treatment options in acute myocarditis, with or without heart failure. | Q38794097 |
| | Percutaneous Mechanical Circulatory Support Using Impella® Devices for Decompensated Cardiogenic Shock: A Pediatric Heart Center Experience. | Q38844356 |
| | Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study | Q39183948 |
| | Myocarditis: A Clinical Overview | Q39328213 |
| | Pathophysiology of Takotsubo Syndrome | Q39367829 |
| | Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis | Q40174684 |
| | Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience | Q40374068 |
| | Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis | Q40625241 |
| | Use of the Impella 5.0 Device as a Bridge to Recovery in Adult Fulminant Viral Myocarditis | Q41363051 |
| | Effect of intravenous immunoglobulin for fulminant myocarditis on in-hospital mortality: propensity score analyses | Q41499585 |
| | Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score | Q41701343 |
| | Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: A retrospective study | Q41821417 |
| | Value of SOFA, APACHE IV and SAPS II scoring systems in predicting short-term mortality in patients with acute myocarditis | Q41998221 |
| | Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support | Q42028943 |
| | Repetitive fulminant influenza myocarditis requiring the use of circulatory assist devices | Q42243012 |
| | Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial | Q42617042 |
| | Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial | Q44360648 |
| | Virus serology in patients with suspected myocarditis: utility or futility? | Q45369959 |
| | Efficacy and cardiovascular tolerability of continuous veno-venous hemodiafiltration in acute decompensated heart failure: a randomized comparative study | Q46233273 |
| | Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. | Q46598601 |
| | Fulminant myocarditis: the role of cardiac magnetic resonance imaging | Q46891630 |
| | Functional Metabolomics Characterizes a Key Role for N-Acetyl-Neuraminic Acid in Coronary Artery Diseases. | Q47275716 |
| | Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema | Q47879922 |
| | Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association | Q47942317 |
| | Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock | Q48631004 |
| | Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance. | Q50885772 |
| | Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. | Q50965471 |
| | Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis. | Q51030790 |
| | Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device. | Q51627518 |
| | Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. | Q52938201 |
| | Noninvasive ventilation in acute cardiogenic pulmonary edema: a meta-analysis of randomized controlled trials. | Q53854142 |
| | 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practic | Q57046951 |
| | Gamma-globulin treatment of acute myocarditis in the pediatric population | Q58478423 |
| | Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care | Q67898108 |
| | The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID) | Q71193604 |
| | Echocardiographic findings in fulminant and acute myocarditis | Q74012871 |
| | Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells | Q74515096 |
| | N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study | Q80428291 |
| | Use of B-type natriuretic peptide for the management of women with dyspnea | Q81119645 |
| | Prognostic electrocardiographic parameters in patients with suspected myocarditis | Q83216384 |
| | Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version | Q83389693 |
| | Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience | Q83446352 |
| | Transbrachial intra-aortic balloon pumping for a patient with fulminant myocarditis | Q83475036 |
| | Human parvovirus B19-associated myocarditis | Q83966184 |
| | Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study | Q84284308 |
| | Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease | Q84441127 |
| | Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure | Q85253469 |
| | Fulminant Myocarditis in Children Successfully Treated with High Dose of Methyl-Prednisolone | Q85553860 |
| | What's new in myocarditis? | Q85898147 |
| | 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart | Q86275159 |
| | Myocarditis | Q87230906 |
| | Interferon-Beta improves survival in enterovirus-associated cardiomyopathy | Q87387305 |
| | Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: a weighted meta-analysis of 170 patients | Q87466811 |
| | Mechanical Circulatory Support in Acute Decompensated Heart Failure and Shock | Q88283805 |
| | Mechanical Support for Cardiogenic Shock: Lost in Translation? | Q88681266 |
| | Immune Checkpoint Inhibitor-Associated Myocarditis | Q88867248 |
| | A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study | Q92238322 |
| P433 | issue | 2 | |
| P921 | main subject | myocarditis | Q186235 |
| P304 | page(s) | 187-202 | |
| P577 | publication date | 2018-12-03 | |
| P1433 | published in | Science in China. Series C: Life Sciences | Q2619480 |
| P1476 | title | Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis | |
| P478 | volume | 62 | |